Nerve-sparing radical prostatectomy (NSRP) for the treatment of prostate cancer (PCA) should be restricted to patients who harbour tumours without capsular penetration. Selection criteria for NSRP are not clearly de®ned. We investigated a panel of preoperative tumour characteristics with respect to their ability to predict organcon®ned tumour growth for each lobe of the prostate to indicate uni-or bilateral NSRP.
Nerve-sparing radical prostatectomy (NSRP) for the treatment of prostate cancer (PCA) should be restricted to patients who harbour tumours without capsular penetration. Selection criteria for NSRP are not clearly de®ned. We investigated a panel of preoperative tumour characteristics with respect to their ability to predict organcon®ned tumour growth for each lobe of the prostate to indicate uni-or bilateral NSRP.
Method
Nine preoperative tumour characteristics of 278 patients with clinically localised PCa were included in a multivariate tree-structured regression analysis. The association of clinical stage, serum prostate speci®c antigen (PSA), PSA density, results of transrectal ultrasonography (TRUS), and results of systematic sextant biopsy (total length of cancerous tissue, number of positive biopsies, Gleason grade, number of biopsies that include highgrade cancer and number of biopsies with predominantly high-grade cancer) with organ-de®ned tumour growth was statistically evaluated. Except for serum PSA and PSA density, the preoperative characteristics were considered separately for each lobe of the prostate. That offered the possibility of estimating the likelihood of organ-con®ned tumour growth side-by-side to determine whether unilateral or bilateral NSRP was indicated. The result of the multivariate analysis was evaluated prospectively on 353 patients.
Results
Multivariate tree-structured regression analysis resulted in four patient groups with de®ned likelihoods of organcon®ned PCa. Of all characteristics included in the analysis, only the number of biopsies with high-grade cancer, the number of biopsies, and serum PSA were independent for predicting organ-con®ned cancer. Patients with PSA below 10 ng/ml and no more than one biopsy with highgrade cancer had a likelihood of organ-con®ned tumour growth of 86%. In the prospective evaluation, the same criteria led to an incidence of organ-con®ned PCa of 88.5%. Considering the characteristics separately for each lobe of the prostate increased the accuracy of predicting organ-con®ned disease from 76% for the whole gland to 86% for each lobe. Clinical stage and simple Gleason grades did not contribute independent information for the prediction of organ-con®ned disease.
Conclusion
Quanti®cation of cancer and high-grade cancer in a systematic biopsy and serum PSA concentration are the most useful preoperative characteristics for prediction of organ-con®ned PCa. A quantitative analysis of the histological results of systematic biopsies of the prostate and serum PSA yield a safe, reproducible, and user-friendly estimation of the likelihood of organ-con®ned cancer growth, which was demonstrated in the validation data set. This is the ®rst time that the results of a quanti®cation of high-grade cancer in preoperative biopsies was incorporated in a preoperative, multivariate analysis for prediction of organ-con®ned disease. In patients with a high likelihood of organ-con®ned cancer, NSRP should be recommended to avoid postoperative erectile dysfunction.
